Successful treatment of refractory neutropenia in Felty's syndrome with rituximab

Scand J Rheumatol. 2018 Jul;47(4):340-341. doi: 10.1080/03009742.2017.1334816. Epub 2017 Jul 28.

Authors

C-R Wang¹, Y-C Chiu², Y-C Chen³

Affiliations

¹ a Department of Internal Medicine, Section of Rheumatology , National Cheng Kung University Hospital , Tainan , Taiwan.
² b Department of Internal Medicine, Section of Gastroenterology , National Cheng Kung University Hospital , Tainan , Taiwan.
³ c Department of Radiology , National Cheng Kung University Hospital , Tainan , Taiwan.

PMID: 28753121
DOI: 10.1080/03009742.2017.1334816

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antirheumatic Agents / therapeutic use*
Felty Syndrome / complications
Felty Syndrome / drug therapy*
Humans
Male
Neutropenia / drug therapy*
Neutropenia / etiology
Rituximab / therapeutic use*
Treatment Outcome

Substances

Antirheumatic Agents
Rituximab